CoChat

Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer

Marcia Hall, Gordon G. Peters · 1996 · Advances in cancer research

The DOI matches its Crossref record; 298 of the 300 references it cites were found in a registry or an index.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0065-230x(08)60352-8

Cites

298 of 298 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 298 references

Research works printed but not linked: 134

  1. Adnane, 1989, Oncogene, 4, 1389
  2. Akiyama, 1994, Cancer Res., 54, 377
  3. Ali, 1989, Oncogene, 4, 89
  4. Athan, 1991, Am. I. Pathol., 138, 591
  5. Bartkova, 1995, Cancer Res., 55, 949
  6. Bartkova, 1995, Oncogene, 10, 775
  7. Bates, 1994, Oncogene, 9, 1633
  8. Beltinger, 1995, Cancer Res., 55, 2053
  9. Berenson, 1990, Oncogene, 5, 1343
  10. Berenson, 1989, Oncogene, 4, 1111
  11. Bhatia, 1995, Cancer Res., 55, 1431
  12. Boggild, 1994, J. Clin. Endocrinol. Metab., 78, 387
  13. Boring, 1993, CA Cancer J. Clin., 43, 7
  14. Brenner, 1995, Cancer Res., 55, 2892
  15. Buckley, 1993, Oncogene, 8, 2127
  16. Bullrich, 1995, Cancer Res., 55, 1199
  17. Cairns, 1995, Cancer Res., 55, 224
  18. Cheng, 1994, Cancer Res., 54, 5547
  19. Cordon-Cardo, 1994, Cancer Res., 54, 794
  20. Cowan, 1993, Cancer Res., 53, 5542
  21. de Boer, 1993, Cancer Res., 53, 4148
  22. de Boer, 1995, Oncogene, 10, 1833
  23. Dreyling, 1995, Cancer Res., 55, 984
  24. Duro, 1995, Oncogene, 11, 21
  25. Fantl, 1993, Cancer Surveys, 18, 77
  26. Faust, 1992, Cancer Res., 52, 2460
  27. Forus, 1993, Cell Growth Differ., 4, 1065
  28. Gaffey, 1993, Mod. Pathol., 6, 654
  29. Giani, 1994, Cancer Res., 54, 6338
  30. Gillett, 1994, Cancer Res., 54, 1812
  31. Gillett, C., Smith, P., Gregory, W., Richards, M., Millis, R., Peters, G., and Barnes, D. (1996). Int. J. Cancer, in press.
  32. Goodrich, 1993, Biochim. Biophys. Acta, 1155, 43
  33. Han, 1995, Oncogene, 10, 953
  34. Hanna, 1993, Oncogene, 8, 1661
  35. Hatada, 1988, Oncogene, 3, 537
  36. Hayashi, 1994, Int. J. Hematol., 59, 281
  37. He, 1994, Cancer Res., 54, 5804
  38. Ince, 1988, Leukemia, 2, 343
  39. Jares, 1994, Cancer Res., 54, 4813
  40. Jen, 1994, Cancer Res., 54, 6353
  41. Jiang, 1992, Cancer Res., 52, 2980
  42. Jiang, 1993, Oncogene, 8, 3447
  43. Jin, 1993, Cancer Res., 53, 2140
  44. Kawamata, 1995, Cancer Res., 55, 2266
  45. Keyomarsi, 1994, Cancer Res., 54, 380
  46. Khatib, 1993, Cancer Res., 53, 5535
  47. Kitagawa, 1991, Cancer Res., 51, 1504
  48. Koduru, 1989, Oncogene, 4, 929
  49. Korsmeyer, 1992, Annu. Rev. Immunol., 10, 785, 10.1146/annurev.iy.10.040192.004033 · doi:10.1146/annurev.iy.10.040192.004033 · Paper page
  50. Lammie, 1991, Cancer Cells, 3, 413
  51. Lammie, 1991, Oncogene, 6, 439
  52. Lammie, 1992, Oncogene, 7, 2381
  53. Leach, 1993, Cancer Res., 53, 1986
  54. Lebwohl, 1994, Oncogene, 9, 1925
  55. Li, 1994, Cancer Res., 54, 6078
  56. Li, 1995, Oncogene, 11, 597
  57. Li, 1995, Oncogene, 10, 599
  58. Lidereau, 1988, Oncogene Res., 2, 285
  59. Liscia, 1989, Oncogene, 4, 1219
  60. Liu, 1995, Oncogene, 10, 1061
  61. Lo, 1995, Cancer Res., 55, 2039
  62. Louie, 1987, Am. J. Hum. Genet. (Suppl.), 41, 31
  63. Lucas, 1994, Int. J. Oncol., 5, 469
  64. Lukas, 1994, Oncogene, 9, 2159
  65. Meeker, 1991, Leukemia, 5, 733
  66. Meltzer, 1991, Cell Growth Differ, 2, 495
  67. Meyers, 1990, Cancer Res., 50, 5911
  68. Michalides, 1995, Cancer Res., 55, 975
  69. Mitra, 1994, Cancer Res., 54, 637
  70. Mori, 1994, Cancer Res., 54, 3396
  71. Motokura, 1993, Biochim. Biophys. Acta, 1155, 63
  72. Moulton, 1995, Am. J. Pathol., 146, 613
  73. Newman, 1993, Blood, 82, 1239, 10.1182/blood.V82.4.1239.1239 · doi:10.1182/blood.v82.4.1239.1239
  74. Nguyen, 1988, Oncogene, 3, 703
  75. Nishida, 1994, Cancer Res., 54, 3107
  76. Ohta, 1994, Cancer Res., 54, 5269
  77. Okamoto, 1995, Cancer Res., 55, 1448
  78. Otsuki, 1995, Cancer Res., 55, 1436
  79. Otterson, 1994, Oncogene, 9, 3375
  80. Palmero, 1993, Oncogene, 8, 1049
  81. Parise, 1994, Int. J. Oncol., 5, 309
  82. Peeper, 1994, Biochim. Biophys. Acta, 1198, 215
  83. Peters, 1990, Cell Growth Differ., 1, 503
  84. Peters, 1991, Sem. Virol., 2, 319
  85. Pietenpol, 1995, Cancer Res., 55, 1206
  86. Ponce-Castañeda, 1995, Cancer Res., 55, 1211
  87. Proctor, 1991, Oncogene, 6, 789
  88. Rabbitts, 1988, Oncogene, 3, 99
  89. Raffeld, 1991, Blood, 78, 259, 10.1182/blood.V78.2.259.bloodjournal782259 · doi:10.1182/blood.v78.2.259.bloodjournal782259 · Paper page
  90. Rasheed, 1994, Cancer Res., 54, 1324
  91. Reifenberger, 1994, Cancer Res., 54, 4299
  92. Resnitzky, 1994, Mol. Cell. Biol., 14, 1669
  93. Roberts, 1989, Cancer Res., 49, 5407
  94. Rogler, 1991, Curr. Topics Microbiol. Irnmunol., 168, 103
  95. Rosenberg, 1991, Oncogene, 6, 449
  96. Rosenberg, 1993, Oncogene, 8, 519
  97. Schmidt, 1994, Cancer Res., 54, 6321
  98. Schultz, 1995, Cancer Res., 55, 2150
  99. Schuuring, 1993, Mol. Cell. Biol., 13, 2891
  100. Schuuring, 1992, Oncogene, 7, 355
  101. Schuuring, 1992, Cancer Res., 52, 5229
  102. Seto, 1992, Oncogene, 7, 1401
  103. Shapiro, 1995, Cancer Res., 55, 505
  104. Smith, 1992, Cancer Res., 52, 3746
  105. Somers, 1990, Oncogene, 5, 915
  106. Speicher, 1995, Cancer Res., 55, 1010
  107. Sun, 1995, Oncogene, 10, 785
  108. Sun, 1995, Cancer Epidem. Biomark. Prev., 4, 261
  109. Szepetowski, 1992, Oncogene, 7, 751
  110. Szepetowski, 1992, Oncogene, 7, 2513
  111. Tam, 1994, Oncogene, 9, 2663
  112. Theillet, 1990, Oncogene, 5, 147
  113. Theillet, 1989, Oncogene, 4, 915
  114. Tsuda, 1989, Cancer Res., 49, 3104
  115. Tsuda, 1989, Jpn. J. Clin. Oncol., 19, 26
  116. Tsuda, 1989, Cancer Res., 49, 5505
  117. Varley, 1988, Oncogene, 3, 87
  118. Wagata, 1991, Cancer Res., 51, 2113
  119. Walker, 1995, Cancer Res., 55, 20
  120. Wang, 1992, Oncogene, 7, 1653
  121. Washimi, 1995, Cancer Res., 55, 514
  122. Weisenburger, 1991, Leukemia, 1, 26
  123. Williams, 1992, Cancer Res., 52, 5541s
  124. Withers, 1991, Mol. Cell. Biol., 11, 4846
  125. Xiao, 1995, Oncogene, 11, 511
  126. Xu, 1994, Cancer Res., 54, 5262
  127. Yang, 1994, Am. J. Pathol., 145, 86
  128. Yoshida, 1994, Oncol. Rep., 1, 493
  129. Yoshida, 1995, Cancer Res., 55, 2756
  130. Zhang, 1994, Cancer Res., 54, 5050
  131. Zhou, 1989, Oncogene, 4, 105
  132. Zhou, 1988, Oncogene, 2, 279
  133. Zhou, 1995, Oncogene, 11, 571
  134. Zhou, 1994, Oncogene, 9, 3737

Cited by

See all 760

Metadata

Authors
Hall, M., & Peters, G. G.
Venue
Advances in cancer research
Publisher
Elsevier
Published
1996
Volume
68
Pages
67-108
ISSN
0065-230X (ISSN-L)
OpenAlex
W1569698611
Cited by
752
References
300
Citations by year
2026: 5 · 2025: 8 · 2024: 7 · 2023: 12 · 2022: 11 · 2021: 20 · 2020: 12 · 2019: 19 · 2018: 15 · 2017: 9 · 2016: 18 · 2015: 21 · 2014: 24 · 2013: 16 · 2012: 19
FWCI
56.53
Type
book chapter
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Advances in cancer research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
Keywords
cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors, human cancer, cyclin D1, CCND1, CDK4, p16, retinoblastoma protein, cell cycle regulation, tumor suppressor, cell proliferation, glioma, sarcoma
MeSH terms
Cell Cycle, Enzyme Inhibitors, Humans, Mutation, Neoplasms, Translocation, Genetic, Oncogene Proteins, Cyclins, Cyclin-Dependent Kinases, Cyclin D1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer. https://app.cochat.ai/papers/10.1016/s0065-230x(08)60352-8
The paper
Hall, M., & Peters, G. G. (1996). Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer. Advances in cancer research. https://doi.org/10.1016/s0065-230x(08)60352-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.